12 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EPIQ Series Diagnostic Ultrasound Systems; Affiniti Series Diagnostic Ultrasound Systems

FDA 510(k)
FDA Class 2 ·Radiology

Spud

FDA UDI
KATENA PRODUCTS, INC.·00841668101216·FRANCIS FOREIGN BODY SPUD

Bioplate®

FDA UDI
Bioplate, Inc.·M384K248500·Maxfax Set Basic

Apelo® / Apelo® MIS

FDA UDI
ATLAS SPINE, INC.·M68169102408500·8.5mm Cannulated Screw Kit

TSY SHOULDER PLATE IMPLANT

FDA 510(k)
FDA Class 2 ·Orthopedic

GENESIS REUSABLE RIGID CONTAINER SYSTEM

FDA 510(k)
FDA Class 2 ·General Hospital

ALARIS SYSTEM

FDA Adverse Event
Malfunction ·CAREFUSION SD·Product code FRN·October 27, 2023

MY3D PERSONALIZED SOLUTIONS

FDA Adverse Event
Injury ·ONKOS SURGICAL·Product code KRO·December 8, 2025

WARM PACK, INSTANT, GEL, 6"X6"

FDA Adverse Event
Other ·MEDLINE INDUSTRIES, INC.·Product code IMD·November 12, 2008

HOYER HML 400

FDA Adverse Event
Malfunction ·APEX HEALTHCARE MFG INC·Product code FNG·August 8, 2011

TRANSTAR STRETCHER

FDA Adverse Event
Malfunction ·HILL-ROM, INC.·Product code FPO·July 16, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014